Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Balzarini

Showing results (391-400 of 563) with videos related to

Pageof 57
Sort By:
AAPS Pharmsci|November 9, 2002
Role of MRP4 and MRP5 in biology and chemotherapyJ Sampath, M Adachi, S Hatse, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1990
Inhibitory effects of potent inhibitors of human immunodeficiency virus and cytomegalovirus on the growth of human granulocyte-macrophage progenitor cells in vitroR Snoeck, L Lagneaux, A Delforge, et al.
Biochemical Pharmacology|April 25, 2009
Identification of aspartic acid-203 in human thymidine phosphorylase as an important residue for both catalysis and non-competitive inhibition by the small molecule "crystallization chaperone" 5'-O-tritylinosine (KIN59)A Bronckaers, L Aguado, A Negri, et al.
Nucleosides & Nucleotides|August 5, 1999
3'-(N-hydroxyimino)-2',3-dideoxynucleosides and their derivatives: synthesis, broad spectrum antiviral properties and synthetical application for the preparation of other nucleoside analoguesI Fedorov, E Kazmina, M Jasko, et al.
Molecular Pharmacology|September 25, 1999
Characterization of the activation pathway of phosphoramidate triester prodrugs of stavudine and zidovudineD Saboulard, L Naesens, D Cahard, et al.
Nucleosides, Nucleotides & Nucleic Acids|October 21, 2003
Towards new thymidine phosphorylase/PD-ECGF inhibitors based on the transition state of the enzyme reactionE M Priego, J Mendieta, F Gago, et al.
Journal of Medicinal Chemistry|September 28, 1998
Inactivation of S-adenosyl-L-homocysteine hydrolase and antiviral activity with 5',5',6',6'-tetradehydro-6'-deoxy-6'-halohomoadenosine analogues (4'-haloacetylene analogues derived from adenosine)M J Robins, S F Wnuk, X Yang, et al.
Biochemical Pharmacology|July 6, 1993
Metabolism and pharmacokinetics of the anti-HIV-1-specific inhibitor [1-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3-N- methyl-thymine]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dio xide)J Balzarini, L Naesens, C Bohman, et al.
Journal of Medicinal Chemistry|February 18, 1994
Antiviral enantiomeric preference for 5'-noraristeromycinS M Siddiqi, X Chen, S W Schneller, et al.
Molecular Pharmacology|January 28, 1998
Intracellular metabolism of the N7-substituted acyclic nucleoside analog 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purine, a potent inhibitor of herpesvirus replicationJ Neyts, J Balzarini, G Andrei, et al.
Pageof 57

Showing results (391-400 of 563) with videos related to

Sort By:
Pageof 57
AAPS Pharmsci|November 9, 2002
Role of MRP4 and MRP5 in biology and chemotherapyJ Sampath, M Adachi, S Hatse, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1990
Inhibitory effects of potent inhibitors of human immunodeficiency virus and cytomegalovirus on the growth of human granulocyte-macrophage progenitor cells in vitroR Snoeck, L Lagneaux, A Delforge, et al.
Biochemical Pharmacology|April 25, 2009
Identification of aspartic acid-203 in human thymidine phosphorylase as an important residue for both catalysis and non-competitive inhibition by the small molecule "crystallization chaperone" 5'-O-tritylinosine (KIN59)A Bronckaers, L Aguado, A Negri, et al.
Nucleosides & Nucleotides|August 5, 1999
3'-(N-hydroxyimino)-2',3-dideoxynucleosides and their derivatives: synthesis, broad spectrum antiviral properties and synthetical application for the preparation of other nucleoside analoguesI Fedorov, E Kazmina, M Jasko, et al.
Molecular Pharmacology|September 25, 1999
Characterization of the activation pathway of phosphoramidate triester prodrugs of stavudine and zidovudineD Saboulard, L Naesens, D Cahard, et al.
Nucleosides, Nucleotides & Nucleic Acids|October 21, 2003
Towards new thymidine phosphorylase/PD-ECGF inhibitors based on the transition state of the enzyme reactionE M Priego, J Mendieta, F Gago, et al.
Journal of Medicinal Chemistry|September 28, 1998
Inactivation of S-adenosyl-L-homocysteine hydrolase and antiviral activity with 5',5',6',6'-tetradehydro-6'-deoxy-6'-halohomoadenosine analogues (4'-haloacetylene analogues derived from adenosine)M J Robins, S F Wnuk, X Yang, et al.
Biochemical Pharmacology|July 6, 1993
Metabolism and pharmacokinetics of the anti-HIV-1-specific inhibitor [1-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3-N- methyl-thymine]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dio xide)J Balzarini, L Naesens, C Bohman, et al.
Journal of Medicinal Chemistry|February 18, 1994
Antiviral enantiomeric preference for 5'-noraristeromycinS M Siddiqi, X Chen, S W Schneller, et al.
Molecular Pharmacology|January 28, 1998
Intracellular metabolism of the N7-substituted acyclic nucleoside analog 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purine, a potent inhibitor of herpesvirus replicationJ Neyts, J Balzarini, G Andrei, et al.
Pageof 57